Overview
- The infographic explains Ebola Virus Disease (EVD) as a severe zoonotic infection with high fatality rates and major long-term health complications.
- It describes how Ebola survivors may experience chronic symptoms such as fatigue, joint pain, headaches, neurocognitive problems, and mental health disorders.
- The infographic highlights ocular complications, including uveitis, blurry vision, and potential vision loss among survivors.
- It emphasizes the importance of multidisciplinary survivor care involving medical, psychological, and social support services.
- The infographic outlines supportive treatment strategies such as fluid resuscitation, oxygen support, electrolyte management, and treatment of coinfections.
- It explains that monoclonal antibody therapies are available for Zaire ebolavirus but remain limited for other Ebola virus species.
- The infographic discusses key outbreak prevention measures, including rapid diagnosis, isolation, contact tracing, safe burials, and infection control practices.
- It highlights the importance of community engagement and risk communication in improving outbreak response and public trust.
- The infographic introduces licensed Ebola vaccines such as ERVEBO and Ad26.ZEBOV + MVA-BN-Filo vaccine regimen.
- It also explores pipeline vaccines and future research aimed at developing broader protection against multiple ebolavirus species.
- The infographic explains ongoing efforts to create broad-spectrum therapeutics capable of targeting multiple filoviruses.
- It concludes that although major scientific progress has been achieved, important gaps still remain in vaccines, therapeutics, survivor care, and healthcare system preparedness.
By Global Health Press
